Wilsonville father’s cancer is stable, thanks to Providence immunotherapy trial
Kyle, husband and father of two young boys, discovered he had thymoma, which is cancer of the thymus. An aggressive tumor in his chest was nearly the size of a grapefruit.
Kyle’s treatment was also aggressive, involving surgery, chemotherapy and radiation. Still, the cancer returned four times, showing up in his spine, lungs and chest.
Two years ago, Kyle learned about a clinical trial at Providence Cancer Institute Franz Clinic for individuals with advanced solid tumors. As part of a Phase 1 trial, Kyle was treated by Rachel Sanborn, M.D. with a new immunotherapy drug called Lorigerlimab.
Today, Kyle’s scans show minimal scarring but no signs of cancer.
“One of my main goals is I did not want to be remembered by stories or in photos. I wanted my children to feel me, touch me, know me and hear my voice.”
Thanks to this philanthropy-supported clinical trial, Kyle’s wish was granted.